Reason for request
Extension of indication
Clinical Benefit
| Substantial |
Substantial in type 1 diabetes in children aged 2 to 5 years. |
Clinical Added Value
| no clinical added value |
LANTUS provides no improvement in actual benefit (IAB V, non-existent) in the management of children aged 2 to 5 years with type 1 diabetes. |
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
jS30gVGmeZXGGd7e
Listen
